Reply to “Reevaluating thromboprophylaxis in COVID-19 outpatients: the case for a targeted, risk-based approach”

ISTH Academy, Faculty / Presenters, 4173995

Residual pulmonary vascular obstruction computed with ventilation/perfusion single photon emission computed tomography/computed tomography to predict the risk of venous thromboembolism recurrence in patients with pulmonary embolism: protocol for a cohort study (PRONOSPECT)

ISTH Academy, , 4173990

C-type lectin-like receptor 2 in platelets amplifies inflammation in rheumatoid arthritis

ISTH Academy, Katsue Suzuki-Inoue, 4173989

Platelet response following dexamethasone in obese vs nonobese patients with primary, acute immune-mediated thrombocytopenia

ISTH Academy, Faculty / Presenters, 4173987

Formation of tight junction-like structures of zonula occludens 2 in platelet–platelet interaction

ISTH Academy, Constance Baaten, 4173979

An assessment of evidence to inform best practice for the communication of acute venous thromboembolism diagnosis: a scoping review

ISTH Academy, , 4173975

Disseminated intravascular coagulation and cirrhotic coagulopathy: overlap and differences. The current state of knowledge. Communication from the SSC of the ISTH

ISTH Academy, Faculty / Presenters, 4157450

Platelet-neutrophil aggregate formation induces NLRP3 inflammasome activation in vaccine-induced thrombotic thrombocytopenia

ISTH Academy, Patricia Bozza, 4157445

Hemophilia B Leyden: characteristics and natural history in the International Pediatric Network of Hemophilia Management Registry

ISTH Academy, Nadine Gretenkort Andersson, 4157434

Impact of diagnostic coding schemas on major bleeding risk assessment for oral anticoagulants in patients with atrial fibrillation using administrative claims data

ISTH Academy, , 4157431

Etiology and diagnosis of heavy menstrual bleeding among adolescent and adult patients: a systematic review and meta-analysis of the literature

ISTH Academy, Paula James, 4157430

Importance of individual residues in hydrophobic patch PLVIVGL (1481-1487) in FV-Short for synergistic TFPIα cofactor activity with protein S, an alanine-scanning study: AlphaFold-mediated prediction of FV-Short/TFPIα/protein S trimolecular complex structure

ISTH Academy, Faculty / Presenters, 4157429

Platelets and megakaryocytes in cancer

ISTH Academy, Emma Josefsson, 4157424

Safe and effective anticoagulation use: case studies in anticoagulation stewardship

ISTH Academy, , 4157422

Therapeutic potential of DNases in immunothrombosis: promising succor or uncertain future?

ISTH Academy, , 4157421

Illustrated Capsules from the Advanced Course in Platelet Research

ISTH Academy, Faculty / Presenters, 4157458

Rebalancing Therapies for Hemophilia: Are You Ready?

ISTH Academy, Faculty / Presenters, 4151244

Factor XI/XIa Inhibitors: Glossary of Terms

ISTH Academy, Faculty / Presenters, 4152057

SSC on the Case: Pediatric and Neonatal Thrombosis and Hemostasis: CSVT and Mesenteric Vein Thrombosis with MIS-C

ISTH Academy, Faculty / Presenters, 4151111

Abelacimab, a "Game Changer" for High-Risk Patients with Afib: Dr Ruff and Dr Bloomfield Elaborate on Latest Date from AZALEA-TIMI 71 Trial

ISTH Academy, Faculty / Presenters, 4151582

OCEANIC-AF trial: factor XI inhibitors revolution in atrial fibrillation is on hold

ISTH Academy, Faculty / Presenters, 4151581

The anticoagulant effects of milvexian, a novel small molecule factor Xia inhibitor, are neturalized by activated prothrombin complex concentrates and recombinant factor VIIa in human plasma and whole blood in vitro

ISTH Academy, Faculty / Presenters, 4151580

Factor XI inhibitors: a new class of anticoagulants

ISTH Academy, Faculty / Presenters, 4151579

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation

ISTH Academy, Faculty / Presenters, 4151578

Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial

ISTH Academy, Faculty / Presenters, 4151577

Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI

ISTH Academy, Faculty / Presenters, 4151576

Factor XI: structure, function, and therapeutic inhibition

ISTH Academy, Faculty / Presenters, 4151575

XI Before X: The Promise of Factor XI Inhibitors

ISTH Academy, Faculty / Presenters, 4151574

Citrullination of tissue factor pathway inhibitor alpha by peptidylarginine deiminase 4 impairs its natural anticoagulant activity toward factors Xa and VIIa/tissue factor and reduces binding to its cofactor protein S

ISTH Academy, R Koenen, 4151497

Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years

ISTH Academy, Faculty / Presenters, 4151498

Non-immunogenic recombinant staphylokinase versus alteplase for patients with massive pulmonary embolism: a randomized open-label, multicenter, parallel-group, non-inferiority trial, FORPE

ISTH Academy, Faculty / Presenters, 4151499

Long-term FXa inhibition attenuates thromboinflammation after acute myocardial infarction and stroke by platelet proteome alteration

ISTH Academy, , 4151500

The dynamic range of immunoassays for heparin-induced thrombocytopenia

ISTH Academy, Michael Nagler, 4151501

Application of platelet transcriptomics for assessing treatment effectiveness and predicting long-term platelet counts recovery in aplastic anemia

ISTH Academy, Jun Shi, 4151502

Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: an Italian multicenter study

ISTH Academy, Flora Peyvandi, 4151503

Integrative phosphoproteomic analyses reveal hemostatic-endothelial signaling interplay

ISTH Academy, Arie Hoogendijk, 4151504

An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

ISTH Academy, Faculty / Presenters, 4151505

Use of antithrombotic therapy in patients with hemophilia: a selected synopsis of the European Hematology Association - International Society on Thrombosis and Haemostasis - European Association for Hemophilia and Allied Disorders - European Stroke Organization Clinical Practice Guidance document

ISTH Academy, Michelle Sholzberg, 4151506

“Thromboplastin calibration revisited to look for possible revision of the World Health Organization recommendations”: comment from Kitchen et al.

ISTH Academy, Faculty / Presenters, 4151507

“Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models”: comment

ISTH Academy, , 4151508

Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models

ISTH Academy, Faculty / Presenters, 4151509

Corrigendum to ‘Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial’

ISTH Academy, Faculty / Presenters, 4151510

Real-world safety and efficacy of rADAMTS13 in the treatment of congenital thrombotic thrombocytopenic purpura in pediatric patients in Poland

ISTH Academy, Faculty / Presenters, 4151496

Catheter-related thrombosis in adults with cancer: a secondary analysis of a prospective randomized controlled trial

ISTH Academy, Faculty / Presenters, 4151495

Machine learning models for risk prediction of cancer-associated thrombosis: a systematic review and meta-analysis

ISTH Academy, , 4151494

Validation of clinical risk assessment scores for venous thromboembolism in patients with cancer: a population-based cohort study

ISTH Academy, Faculty / Presenters, 4151493

Risk assessment and management strategies in older patients with acute pulmonary embolism

ISTH Academy, , 4151492

Mechanistic basis of activation and inhibition of protein disulfide isomerase by allosteric antithrombotic compounds

ISTH Academy, Nicola Pozzi, 4151491

Insoluble proteomics analysis of acute intracranial large vessel occlusive thrombus

ISTH Academy, Yuming Xu, 4151490

Validating International Classification of Diseases Code 10th Revision algorithms for accurate identification of pulmonary embolism

ISTH Academy, Faculty / Presenters, 4151489

Rivaroxaban, in combination with low-dose aspirin, is associated with a reduction in proinflammatory and prothrombotic circulating vesicle signatures in patients with cardiovascular disease

ISTH Academy, Patricia Maguire, 4151487

Pazopanib in treatment of hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding

ISTH Academy, Faculty / Presenters, 4151486

Biophysical characterization of blood coagulation factor VIII binding to lipid nanodiscs that mimic activated platelet surfaces

ISTH Academy, P. Clint Spiegel, 4151485

Comparing one stage, chromogenic assay results and discrepancies with bleeding phenotype and genetic variants in females with hemophilia A

ISTH Academy, Faculty / Presenters, 4151484

Hemostatic derangements associated with cardiopulmonary bypass predict outcomes in pediatric patients undergoing corrective heart surgery

ISTH Academy, Joseph Palumbo, 4151483

Examining downstream effects of concizumab in hemophilia A with a mathematical modeling approach

ISTH Academy, Karin Leiderman, 4151482

The severe von Willebrand disease variant p.M771V leads to impaired anterograde trafficking of von Willebrand factor in patient-derived and base-edited endothelial colony-forming cells

ISTH Academy, Ruben Bierings, 4151481

Intensive FVIII replacement in hemophilia patients with hypertrophic synovium: a randomized study

ISTH Academy, Faculty / Presenters, 4151480

Persistent splenic-derived IgMs preferentially recognize factor VIII A2 and C2 domain epitopes but do not alter antibody production

ISTH Academy, Glaivy Batsuli, 4151479

Pregnancy loss in individuals with von Willebrand disease and unspecified mucocutaneous bleeding disorders: a multicenter cohort study

ISTH Academy, Faculty / Presenters, 4151478

Thrombotic complications in pregnancy: a case-based review of the evidence

ISTH Academy, Faculty / Presenters, 4151477

Splanchnic vein thrombosis: management for the thrombosis specialist

ISTH Academy, Kenneth Bauer, 4151476

Love for lysis in the time of catheters: is it time to resurrect an old standby?

ISTH Academy, Gregory Piazza, 4151475

Evaluating plasma vesicle signatures in chronic coronary artery disease patients for tailored dual therapy with low-dose rivaroxaban and aspirin

ISTH Academy, Faculty / Presenters, 4151474

Reuse, recycle, repurpose: pazopanib for bleeding in hereditary hemorrhagic telangiectasia

ISTH Academy, Hanny Al-Samkari, 4151473

Molecular basis of platelet granule defects

ISTH Academy, Walter Kahr, 4151472

Deconstructing fibrin(ogen) structure

ISTH Academy, Nathan Hudson, 4151471

Guidelines and guidance: what is the path forward for the ISTH?

ISTH Academy, James Douketis, 4151470

Guidelines and guidance: what is the path forward for the ISTH?

ISTH Academy, James Douketis, 4173996

Deconstructing fibrin(ogen) structure

ISTH Academy, Nathan Hudson, 4173997

Molecular basis of platelet granule defects

ISTH Academy, Walter Kahr, 4173998

Reuse, recycle, repurpose: pazopanib for bleeding in hereditary hemorrhagic telangiectasia

ISTH Academy, Hanny Al-Samkari, 4173999

Evaluating plasma vesicle signatures in chronic coronary artery disease patients for tailored dual therapy with low-dose rivaroxaban and aspirin

ISTH Academy, Faculty / Presenters, 4174000

Love for lysis in the time of catheters: is it time to resurrect an old standby?

ISTH Academy, Gregory Piazza, 4174001

Splanchnic vein thrombosis: management for the thrombosis specialist

ISTH Academy, Kenneth Bauer, 4174002

Thrombotic complications in pregnancy: a case-based review of the evidence

ISTH Academy, Faculty / Presenters, 4174003

Pregnancy loss in individuals with von Willebrand disease and unspecified mucocutaneous bleeding disorders: a multicenter cohort study

ISTH Academy, Faculty / Presenters, 4174004

Persistent splenic-derived IgMs preferentially recognize factor VIII A2 and C2 domain epitopes but do not alter antibody production

ISTH Academy, Glaivy Batsuli, 4174005

Intensive FVIII replacement in hemophilia patients with hypertrophic synovium: a randomized study

ISTH Academy, Faculty / Presenters, 4174006

The severe von Willebrand disease variant p.M771V leads to impaired anterograde trafficking of von Willebrand factor in patient-derived and base-edited endothelial colony-forming cells

ISTH Academy, Ruben Bierings, 4174007

Biophysical characterization of blood coagulation factor VIII binding to lipid nanodiscs that mimic activated platelet surfaces

ISTH Academy, P. Clint Spiegel, 4174011

Validation of clinical risk assessment scores for venous thromboembolism in patients with cancer: a population-based cohort study

ISTH Academy, Faculty / Presenters, 4174019

Machine learning models for risk prediction of cancer-associated thrombosis: a systematic review and meta-analysis

ISTH Academy, , 4174020

Catheter-related thrombosis in adults with cancer: a secondary analysis of a prospective randomized controlled trial

ISTH Academy, Faculty / Presenters, 4174021

Real-world safety and efficacy of rADAMTS13 in the treatment of congenital thrombotic thrombocytopenic purpura in pediatric patients in Poland

ISTH Academy, Faculty / Presenters, 4174022

Citrullination of tissue factor pathway inhibitor alpha by peptidylarginine deiminase 4 impairs its natural anticoagulant activity toward factors Xa and VIIa/tissue factor and reduces binding to its cofactor protein S

ISTH Academy, R Koenen, 4174023

Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years

ISTH Academy, Faculty / Presenters, 4174024

Non-immunogenic recombinant staphylokinase versus alteplase for patients with massive pulmonary embolism: a randomized open-label, multicenter, parallel-group, non-inferiority trial, FORPE

ISTH Academy, Faculty / Presenters, 4174025

Long-term FXa inhibition attenuates thromboinflammation after acute myocardial infarction and stroke by platelet proteome alteration

ISTH Academy, , 4174026

The dynamic range of immunoassays for heparin-induced thrombocytopenia

ISTH Academy, Michael Nagler, 4174027

Application of platelet transcriptomics for assessing treatment effectiveness and predicting long-term platelet counts recovery in aplastic anemia

ISTH Academy, Jun Shi, 4174028

Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: an Italian multicenter study

ISTH Academy, Flora Peyvandi, 4174029

Integrative phosphoproteomic analyses reveal hemostatic-endothelial signaling interplay

ISTH Academy, Arie Hoogendijk, 4174030

An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

ISTH Academy, Faculty / Presenters, 4174031

Use of antithrombotic therapy in patients with hemophilia: a selected synopsis of the European Hematology Association - International Society on Thrombosis and Haemostasis - European Association for Hemophilia and Allied Disorders - European Stroke Organization Clinical Practice Guidance document

ISTH Academy, Michelle Sholzberg, 4174032

“Thromboplastin calibration revisited to look for possible revision of the World Health Organization recommendations”: comment from Kitchen et al.

ISTH Academy, Faculty / Presenters, 4174033

“Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models”: comment

ISTH Academy, , 4174034

Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models

ISTH Academy, Faculty / Presenters, 4174035

Corrigendum to ‘Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial’

ISTH Academy, Faculty / Presenters, 4174036

Annoucements

ISTH Academy, Faculty / Presenters, 4174037